Pliant Therapeutics Inc.

AI Score

0

Unlock

12.00
0.76 (6.76%)
At close: Jan 15, 2025, 1:44 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -161.34M -123.32M -97.26M -41.53M -631.00K -30.28M -18.33M
Depreciation & Amortization 1.84M 1.82M 1.53M 1.31M 1.11M 666.00K 292.00K
Stock-Based Compensation 44.48M 22.60M 10.44M 3.90M 1.83M 228.00K 33.00K
Other Working Capital -3.70M 5.55M -1.25M -17.00K 50.00K 294.00K 893.00K
Other Non-Cash Items -2.60M 52.00K 2.93M 266.00K 12.20M 1.05M 191.00K
Deferred Income Tax n/a n/a n/a n/a -12.20M n/a n/a
Change in Working Capital 1.25M 4.22M 6.92M -1.21M -5.06M 1.05M 893.00K
Operating Cash Flow -116.36M -94.63M -75.44M -37.27M -2.75M -28.33M -16.92M
Capital Expenditures -921.00K -1.76M -1.95M -1.53M -964.00K -2.32M -1.41M
Acquisitions n/a 148.44M -75.65M 209.33M 254.00K n/a n/a
Purchase of Investments -583.07M -325.72M -219.89M -322.61M -51.97M n/a n/a
Sales Maturities Of Investments 456.98M 177.27M 295.54M 113.27M 35.00M n/a n/a
Other Investing Acitivies n/a -148.44M 75.65M -209.33M -254.00K n/a n/a
Investing Cash Flow -127.01M -150.20M 73.70M -210.87M -17.93M -2.32M -1.41M
Debt Repayment n/a 10.00M n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a -12.00K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -847.00K 216.85M -457.00K 52.02M 45.37M 174.67M 20.02M
Financial Cash Flow 274.40M 226.85M 2.53M 213.21M 45.54M 87.35M 20.01M
Net Cash Flow 31.03M -17.98M 783.00K -34.92M 24.86M 56.70M 1.68M
Free Cash Flow -117.28M -96.39M -77.40M -38.80M -3.71M -30.65M -18.33M